Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Heparin-Protein Interactions
2002 Standout
Anticoagulation in pregnant women with mechanical heart valve prostheses
1999
Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy
2004
Thrombophilia and its impact on pregnancy
2009
Anticoagulation of Pregnant Women With Mechanical Heart Valves
2000
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
2007 Standout
Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling
2008
Cerebral venous and sinus thrombosis
2004
The natural history and epidemiology of venous thrombosis
1994
Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura
1994
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
The warfarin embryopathy: A rat model showing maxillonasal hypoplasia and other skeletal disturbances
1992
Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia
2005
Heparin Cofactor II
1997
Vitamin B12 and the Risk of Neural Tube Defects in a Folic-Acid-Fortified Population
2007
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
Recognition, diagnosis, and treatment of primary focal hyperhidrosis
2004 Standout
Preconception Counseling for Women With Thrombophilia
2006
Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia
1997
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review
2008
Preeclampsia and future cardiovascular risk
2007
WHO analysis of causes of maternal death: a systematic review
2006 Standout
The Effect of Race and Sex on Physicians' Recommendations for Cardiac Catheterization
1999 Standout
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Uric Acid and Cardiovascular Risk
2008 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
1996
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study
2008
Cardiovascular Health and Disease in Women
1993
Modern Management of Prosthetic Valve Anticoagulation
1998
Anticoagulation of Pregnant Women With Mechanical Heart Valves
2003
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Management of pregnant women with mechanical heart valve prosthesis: Thromboprophylaxis with Low molecular weight heparin
2009
Antithrombotic Therapy for VTE Disease
2012 Standout
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Cleft lip and palate
2009 Standout
Pre-eclampsia
2005 Standout
Chronic Idiopathic Thrombocytopenic Purpura
1994
Pregnancy and prosthetic heart valves
1994
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
Guidelines on the use and monitoring of heparin
2006
Use of Antithrombotic Agents During Pregnancy
2004
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
2005 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
The Antiphospholipid Syndrome
2002 Standout
Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes
2012
Comparison of Platelet Counts in First and Second Newborns of Mothers With Immune Thrombocytopenic Purpura
1997
Maternal body mass index and the risk of preeclampsia: a systematic overview.
2003
Pharmacodynamics, Clinical Indications, and Adverse Effects of Heparin
1992
HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE EFFECTS OF HEPARIN THERAPY
1998
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Fetal platelet counts in thrombocytopenic pregnancy
1990
Pre-eclampsia
2010 Standout
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2008
Management of Immune Thrombocytopenic Purpura in Adults
2004
Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura
1990
Hypertensive Disorders of Pregnancy and Long-Term Risk of Hypertension: What Do Ontario Prenatal Care Providers Know and What Do They Communicate?
2007
Obstetric Complications in Patients with Hereditary Thrombophilia Identified Using the LCx Microparticle Enzyme Immunoassay
2007
Maternal Overweight and Obesity and the Risk of Congenital Anomalies
2009 Standout
The detection, investigation and management of hypertension in pregnancy: full consensus statement
2000
The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura
1995
Advances in the diagnosis of idiopathic thrombocytopenic purpura
2000
Perinatal management of women with immune thrombocytopenic purpura: Survey of United States perinatologists
1999
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2012
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Heparin-induced thrombocytopenia is rare in pregnancy
2001
Heparin
1991
Folate and human reproduction
2006
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy
2014
Thrombophilia in pregnancy: a systematic review
2005
Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis
2014
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Instituting Surveillance Guidelines and Adverse Outcomes in Preeclampsia
2007
Management of idiopathic thrombocytopenic purpura in pregnancy
2000
Management of Venous Thromboembolism
1996
Management of pregnancy in women with previous left ilio-caval stenting
2009
Pre-eclampsia
2015 Standout
Management of Anticoagulation before and after Elective Surgery
1997
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Are Maternal Deaths on the Ascent in Singapore? A Review of Maternal Mortality as Reflected by Coronial Casework from 1990 to 1999
2002
Maturation of the hemostatic system during childhood
1992 Standout
Adverse Effects of Screening for Gestational Diabetes: A Prospective Cohort Study in Toronto, Canada
1997
Serpin Structure, Mechanism, and Function
2002 Standout
Maternal Body Mass Index and the Risk of Preeclampsia: A Systematic Overview
2003
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
2005
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura
2007
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Pregnancy-associated thrombocytopenia: pathogenesis and management
1992
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
1994
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
How I treat idiopathic thrombocytopenic purpura (ITP)
2005
Risk Factors for Pregnancy Associated Venous Thromboembolism
1997
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Prevention of Orofacial Clefts: Does Pregnancy Planning Have a Role?
2006
Use of Antithrombotic Agents During Pregnancy
2001
Use of Antithrombotic Agents During Pregnancy
1995
Low-Molecular-Weight Heparins
1997 Standout
Anticoagulation in Pregnant Women With Prosthetic Heart Valves
2004
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Venous thrombosis: a multicausal disease
1999 Standout
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
THROMBOPHLEBITIS AND PULMONARY EMBOLISM IN THE ELDERLY PATIENT
1993
The molecular immunology of human platelet proteins
1992
Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension
2005
Works of Robert Burrows being referenced
Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy.
1997
Platelet specific alloantigens on the platelet glycoprotein Ia/IIa complex
1989
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.
1992
Pregnancy in Patients With Idiopathic Thrombocytopenic Purpura
1993
Alloimmune neonatal thrombocytopenia associated with incidental maternal thrombocytopenia
1990
Assessing the Teratogenic Potential of Angiotensin‐Converting Enzyme Inhibitors in Pregnancy
1998
Thrombin Regulation in Mother and Fetus During Pregnancy
1992
Gestational Thrombocytopenia
1999
Use of antihypertensive medications in pregnancy and the risk of adverse perinatal outcomes: McMaster Outcome Study of Hypertension In Pregnancy 2 (MOS HIP 2)
2001
Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia
1993
Evidence for suboptimal use of periconceptional folic acid supplements globally
2004
MOS HIP: McMaster outcome study of hypertension in pregnancy
2001
A randomised double‐blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study
2001
Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism
2000
Thrombocytopenia at delivery: A prospective survey of 6715 deliveries
1990
Incidentally Detected Thrombocytopenia in Healthy Mothers and Their Infants
1988
Heparin Effect on Bone Density
1990
Anticoagulation in pregnancy and the puerperium: A Working Group on behalf of the Obstetric Medicine Group of Australasia
2001
Influence of maternal insulin-dependent diabetes mellitus on neonatal morbidity.
1993
Venous Thrombosis during Pregnancy: Leg and Trimester of Presentation
1992
Prothrombin G20210A mutation is not associated with recurrent miscarriages
2002
A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study
2001
The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density
1996
The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study.
1996
A prospective study investigating the mechanism of thrombocytopenia in preeclampsia.
1987
Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy.
1997
Subcutaneous Heparin Therapy during Pregnancy: a Need for Concern at the Time of Delivery
1991
Risks to the Fetus of Anticoagulant Therapy During Pregnancy
1989
Risks to the Fetus of Anticoagulant Therapy during Pregnancy
1990